Литература

1. Ewig S., Woodhead M., Torres A. Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med. 2011;37:214–23.

2. Menendez R., Torres A. Treatment failure in community-acquired pneumonia.

3. Low D.E., Mazulli T., Marrie T.J. Progressive and nonresolving pneumonia. Curr. Opin. Pulm. Med 2005;11:247–52.

4. Roson B., Carratala J., Fernandez-Sabe N., et al. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch. Intern. Med. 2004;164:502–08.

5. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America / American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007;44:S27–72.

6. Montravers P., Fagon J.Y., Chastre J., et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am. Rev. Respir. Dis. 1993;147:38–44.

7. Kheir F., Hamdi T., Khayr W., et al. Nonresolving pneumonia. Am. J. Ther. 2011;18:77–9.

8. Aliberti S., Amir A., Peyrani P., et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest. 2008;134:955–62.

9. Aliberti S., Blasi F. Clinical stability versus clinical failure in patients with community-acquired pneumonia. Semin. Respir. Crit. Care Med. 2012;33:284–91.

10. Arancibia F., Ewig S., Martinez J.A., et al. Antimicrobial treatment failures in patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2000;162:154–60.

11. Menendez R., Torres A., Zalacain R., et al. Risk factors of treatment failure in community-acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960–65.

12. Menendez R., Torres A., Reyes S., et al. Initial management of pneumonia and sepsis: factors associated with improved outcome.

13. Arancibia F., Ewig S., Martinez J.A., et al. Antimicrobial treatment failures in patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2000;162:154–60.

14. Celis M.R., Torres A., Zalacain R., et al. Working group for the study, diagnosis and treatment of CAP in Spain (NACE). Diagnostic methods and treatment of community-acquired pneumonia in Spain: NACE study. Med. Clin. (Barc). 2002;119:321–26.

15. Sialer S., Liapikou A., Torres A. What is the best approach to the nonresponding patient with community-acquired pneumonia? Infect. Dis. Clin. N. Am. 2013;27:189–203.

16. Woods C., Colice G. Methicillin-resistant Staphylococcus aureus pneumonia in adults. Expert. Rev. Respir. Med. 2014;17:1–11.

17. Franquet T. Imaging of pneumonia: trends and algorithms. Eur. Respir. J. 2001;18:196–208.

18. Washington L., Palacio D. Imaging of bacterial pulmonary infection in the immunocompetent patient. Semin. Roentgenol. 2007;42:122–45.

19. Sanyal S., Smith P.R., Saha A.C., et al. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 1999;160:346–48.

20. Menendez R., Torres A., Zalacain R., et al. Guidelines for the treatment of community-acquired pneumonia. Predictors of adherence and outcome. Am. J. Respir. Crit. Care Med. 2005;172:757–62.

21. Aliberti S., Di Pasquale M., Zanaboni A.M., et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin. Infect. Dis. 2012;54:470–78.

22. Shorr A.F., Zilberberg M.D., Micek S.T., et al. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch. Intern. Med. 2008;168:2205–10.

23. Kirtland S., Witerbauer R. Slowly resolving, chronic, and recurrent pneumonia. Clin. Chest. Med. 1991;12:303–18.